Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ribociclib
Related studies linked through entity extraction aliases.
A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer
- Status
- COMPLETED
- Phase
- N/A
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
- Status
- TERMINATED
- Phase
- PHASE3
Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Ribociclib and Letrozole Treatment in Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant
- Status
- COMPLETED
- Phase
- PHASE3
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
- Status
- COMPLETED
- Phase
- PHASE1
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2